Justice Department sues one of the largest drug distributors in the U.S.
The Justice Department filed a civil lawsuit on Tuesday against one of the largest drug distributors in the U.S., AmerisourceBergen Corp., Politico reports. The DOJ alleges that the company failed to report "at least hundreds of thousands" of suspicious opioid orders to the Drug Enforcement Agency.
The Controlled Substances Act requires pharmaceutical distributors to monitor orders for controlled substances and flag any orders that seem suspicious to the DEA. AmerisourceBergen allegedly failed to report suspicious orders repeatedly since 2014, despite being notified of major "red flags" at pharmacies throughout the country, per the civil court filing. The DOJ believes that AmerisourceBergen knowingly sent drugs to at least five pharmacies they knew were engaged in suspicious behavior, including two in Florida and West Virginia where drugs "were likely being sold in parking lots for cash," per Politico.
"In the midst of a catastrophic opioid epidemic, AmerisourceBergen allegedly altered its internal systems in a way that reduced the number of orders that would be flagged as suspicious. And even up to the orders that AmerisourceBergen identified as suspicious, the company routinely failed to report those suspicious orders," Associate Attorney General Vanita Gupta said during a press call on Thursday.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
If the court finds AmerisourceBergen liable, the company could face civil penalties "potentially totaling billions of dollars," Gupta said. The company has already had to pay billions for its role in exasperating the opioid crisis, including $6.1 billion in settlements for thousands of lawsuits in February. The latest lawsuit comes as the opioid epidemic continues to plague the country. In December, the Centers for Disease Control and Prevention released a report revealing that life expectancy in the U.S. dropped for the second year in a row. Experts attribute this decline to opioid overdoses and the COVID pandemic.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
The Week’s big New Year’s Day quiz 2026Quiz of the Year How much do you remember about 2025’s headlines? Put yourself to the test with our bumper quiz of the year
-
Is tanking ruining sports?Today's Big Question The NBA and the NFL want teams to compete to win. What happens if they decide not to?
-
‘Netflix needs to not just swallow HBO but also emulate it’instant opinion Opinion, comment and editorials of the day
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
Nitazene is quietly increasing opioid deathsThe explainer The drug is usually consumed accidentally
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
